State Street Corporation 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-16 12:48 pm Purchase |
2024-09-30 | 13G | Protagonist Therapeutics, Inc. PTGX |
STATE STREET CORP STT |
3,183,542 5.400% |
453,613 (+16.62%) |
Filing |
| 2024-01-23 10:55 am Sale |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
STATE STREET CORP STT |
2,729,929 4.730% |
-1,062,997 (-28.03%) |
Filing |
| 2023-01-10 08:18 am Sale |
2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
STATE STREET CORP STT |
3,792,926 7.710% |
-2,983,343 (-44.03%) |
Filing |
| 2022-07-11 11:51 am Purchase |
2022-06-30 | 13G | Protagonist Therapeutics, Inc. PTGX |
STATE STREET CORP STT |
6,776,269 13.930% |
4,204,699 (+163.51%) |
Filing |
| 2022-02-10 3:41 pm Purchase |
2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
STATE STREET CORP STT |
2,571,570 5.390% |
2,571,570 (New Position) |
Filing |